You’re using a public version of DrugChatter with 1 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

What are the income requirements for vascepa assistance?



Vascepa is a prescription drug used to treat high levels of triglycerides in the blood. It is important to note that the income requirements for Vascepa assistance may vary depending on the program and eligibility criteria.

One program that offers assistance for Vascepa is the Vascepa Savings Card [2]. This program provides eligible patients with a savings of up to $75 on each Vascepa prescription. To be eligible for the program, patients must have commercial insurance, not be enrolled in a state or federally funded program, and meet certain income requirements. The website states that patients with an annual household income of up to $125,000 may be eligible for the program.

Another program that offers assistance for Vascepa is the Patient Assistance Program [3]. This program is designed for uninsured or underinsured patients who meet certain income requirements. The website states that patients with an annual household income of up to $48,720 for individuals or $65,840 for couples may be eligible for the program.

It is important to note that these income requirements are subject to change and may vary depending on the program. Patients should consult with their healthcare provider or the program website for the most up-to-date information on eligibility criteria and income requirements.

Sources:
[2] https://www.vascepa.com/getting-started/vascepa-savings/
[3] https://www.needymeds.org/drug_list.taf?_function=name&name=Vascepa



Follow-up:   How do I apply for Vascepa assistance? Is Vascepa assistance available for all income levels? What is the maximum income to qualify for Vascepa assistance?





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved.